Navigation Links
SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
Date:4/23/2008

IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles and opinions on the subject and sector.

Investors can view SectorWatch.biz MarketStats by visiting: http://www.SectorWatch.biz -- a division of financial news hub SmallCapSentinel.com

Today's MarketStats on diagnostic companies include: Kraig Biocraft Laboratories, Inc. (OTC Bulletin Board: KBLB), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Bio-Reference Laboratories Inc. (NasdaqGS: BRLI) and Abbott Laboratories (NYSE: ABT).

To view a complete StockUpTicks.com profile on Kraig Biocraft Laboratories, Inc. visit http://stockupticks.com/profiles/3-10-08.html

Visit SectorWatch's parent site SmallCapSentinel.com for a Biotechnology message board and to read or contribute articles on the subject. Users are invited to post editorials and messages on the website. Intelligent articles submitted through the site will be posted as Member Editorials for review by the investing public. http://smallcapsentinel.com/stock/healthcare-biotechnology/biotechnology%3A - research-therapeutics-discovery (Please copy and paste into your web browser)

MarketStats provide snapshots and analysis on public equities making news, driving industry sectors and affecting the markets. SectorWatch.biz is powered by Market Pathways, a leader in the representation of Small Cap equities for over twenty-five years and your discovery zone for under-followed stocks emerging in the market.

Interested investors may subscribe to our StockUpTicks newsletter featuring a treasure trove of promising companies, daily market movers and free personal investment information -- visit http://stockupticks.com/register.html. D.R. Clark of Market Pathways is a member of the National Association of Securities Dealers, CRD # 4518163.

Contact us directly to have your company featured in StockUpTicks.com or SectorWatch.biz. For D.R. Clark's perspective on personal finance and the markets visit http://www.ClarkReport.com

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SectorWatch.biz and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report.

This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid thirty thousand dollars by Kraig Biocraft Laboratories, Inc. for preparation and distribution of this report and other services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.


'/>"/>
SOURCE SectorWatch.biz
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
2. Pharmos Issues Letter to Shareholders
3. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
4. HHS Issues First Department-Wide Report on Personalized Health Care
5. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. CCPM Issues Statement on FDAs GIVE Initiative
8. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
9. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental ... samples to full-size tissues, bones, even whole organs to implant in people to ... blood deep into the developing tissue. , Current bioengineering techniques, including 3-D ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
Breaking Biology Technology:
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
Breaking Biology News(10 mins):